WORCESTER, Mass., July 17, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, will sponsor a symposium in Damascus, Syria with the Syrian Endocrine Society, on July 18, 2008. The symposium is being held to provide education and training for Middle Eastern endocrinologists on the treatment of diabetes mellitus using Generex Oral-lyn(tm), the Company’s proprietary oral insulin spray product, as well as the Company’s proprietary RapidMist(tm) drug delivery device. The symposium will be held at the Sheraton Sednaya Resort, hosted by the Generex MENA office. More than fifty endocrinologists from Syria, Yemen, Algeria, and Morocco are expected to participate.
